DexCom, Inc. Stock Sao Paulo
Equities
D1EX34
BRD1EXBDR004
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.2 BRL | -1.12% | -1.12% | +8.55% |
05-30 | Redburn Atlantic Initiates DexCom With Neutral Rating, $130 Price Target | MT |
05-24 | Declaration of Voting Results by DexCom, Inc | CI |
Sales 2024 * | 4.33B 22.67B 5.91B | Sales 2025 * | 5.15B 26.97B 7.03B | Capitalization | 47.23B 247B 64.42B |
---|---|---|---|---|---|
Net income 2024 * | 732M 3.83B 998M | Net income 2025 * | 910M 4.76B 1.24B | EV / Sales 2024 * | 11.2 x |
Net Debt 2024 * | 1.43B 7.51B 1.96B | Net Debt 2025 * | 994M 5.2B 1.36B | EV / Sales 2025 * | 9.36 x |
P/E ratio 2024 * |
65.7
x | P/E ratio 2025 * |
53.7
x | Employees | 9,550 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.62% |
Latest transcript on DexCom, Inc.
1 day | -1.12% | ||
1 week | -1.12% | ||
1 month | +3.29% | ||
3 months | +14.68% | ||
6 months | +16.09% | ||
Current year | +8.55% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 07-10-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 18-08-31 |
Chief Tech/Sci/R&D Officer | 47 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 65 | 09-11-19 |
Mark Foletta
BRD | Director/Board Member | 63 | 14-11-18 |
Eric Topol
BRD | Director/Board Member | 69 | 09-07-08 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.58% | 178B | |
-1.11% | 107B | |
-2.57% | 67.04B | |
+11.30% | 44.62B | |
+9.25% | 42.5B | |
+14.74% | 29.99B | |
+15.97% | 25.22B | |
-6.46% | 24.14B | |
-6.37% | 23.69B |
- Stock Market
- Equities
- DXCM Stock
- D1EX34 Stock